Literature DB >> 15770138

Differentiation between malignant and benign pleural effusion in patients with extra-pleural primary malignancies: assessment with positron emission tomography-computed tomography.

Jacob S Toaff1, Ur Metser, Maya Gottfried, Odelia Gur, Maher E Deeb, Gennady Lievshitz, Diego Mercer, Einat Even-Sapir.   

Abstract

OBJECTIVES: We sought to define an accurate diagnostic approach for differentiating benign from malignant pleural effusion on positron emission tomography-computed tomography (PET-CT).
MATERIAL AND METHODS: PET-CT studies of 31 patients with primary extrapleural malignancy and pleural effusion were reviewed retrospectively. CT parameters assessed were size and density (Hounsfield units, or HU) of the effusion and density (HU) and morphology of any solid pleural abnormality. Interpretation of PET data included review of the attenuation-corrected and nonattenuation-corrected images.
RESULTS: PET-CT parameters that were found to be significant in identifying malignant pleural effusion included focal increased uptake of 18-fluorodeoxyglucose in the pleura (P<0.0001) and the presence of solid pleural abnormalities on CT (P<0.002): the sensitivity was 86% and 71%, respectively, and the specificity was 90% for each of the 2 parameters. A PET-CT pattern composed of pleural uptake and increased effusion activity on nonattenuation-corrected images was associated with sensitivity of 95%, specificity of 80%, positive predictive value of 91%, negative predictive value of 89%, and accuracy of 90%.
CONCLUSIONS: On PET-CT, the presence of concomitant pleural abnormalities is the most accurate criterion in determining the malignant nature of pleural effusion.

Entities:  

Mesh:

Year:  2005        PMID: 15770138     DOI: 10.1097/01.rli.0000154217.71461.b4

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  8 in total

Review 1.  Diagnostic imaging in the preoperative management of lung cancer.

Authors:  Kazuhiro Imai; Yoshihiro Minamiya; Hajime Saito; Satoru Motoyama; Yusuke Sato; Aki Ito; Kei Yoshino; Satoshi Kudo; Shinogu Takashima; Yasushi Kawaharada; Nobuyasu Kurihara; Kimito Orino; Jun-Ichi Ogawa
Journal:  Surg Today       Date:  2013-07-10       Impact factor: 2.549

Review 2.  Video assisted thoracoscopic and open chest surgery in diagnosis and treatment of malignant pleural diseases.

Authors:  Periklis Perikleous; David A Waller
Journal:  J Vis Surg       Date:  2017-06-22

3.  Developing a Prediction Score for the Diagnosis of Malignant Pleural Effusion: MPE Score.

Authors:  Chaichana Chantharakhit; Nantapa Sujaritvanichpong
Journal:  Asian Pac J Cancer Prev       Date:  2022-01-01

Review 4.  Imaging features of extranodal involvement in paediatric Hodgkin lymphoma.

Authors:  Suzanne Spijkers; Annemieke S Littooij; Paul D Humphries; Marnix G E H Lam; Rutger A J Nievelstein
Journal:  Pediatr Radiol       Date:  2018-12-05

Review 5.  Staging non-small cell lung cancer.

Authors:  Leslie Eisenbud Quint
Journal:  Cancer Imaging       Date:  2007-10-22       Impact factor: 3.909

Review 6.  Thoracic complications and emergencies in oncologic patients.

Authors:  Leslie E Quint
Journal:  Cancer Imaging       Date:  2009-10-02       Impact factor: 3.909

7.  Diagnostic Ability of FDG-PET/CT in the Detection of Malignant Pleural Effusion.

Authors:  Reiko Nakajima; Koichiro Abe; Shuji Sakai
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.817

8.  The Role of 18F-FDG PET/CT Integrated Imaging in Distinguishing Malignant from Benign Pleural Effusion.

Authors:  Yajuan Sun; Hongjuan Yu; Jingquan Ma; Peiou Lu
Journal:  PLoS One       Date:  2016-08-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.